By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 14, 2023
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #2 focuses on updates from the July subcommittee meetings and full meeting of the Natural Medicine Advisory Board.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 14, 2023
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #1 focuses on the Natural Medicine Advisory Board: What is the board, how does the board work, what subcommittees exist, what have they done so far, and what's next?
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 11, 2023
Vicente LLP is collaborating with Psychedelic Alpha to produce the Colorado Natural Medicine Health Act Tracker, which is dedicated to being a clearinghouse for the implementation of Colorado’s Natural Medicine Health Act, with a focus on the work of the Natural Medicine Advisory Board and its subcommittees.
By David M. Ullian and Jennifer L. Flanagan
Aug 9, 2023
A new law is making significant changes to the cannabis industry in Massachusetts, particularly with respect to Host Community Agreements and municipal equity. Read this article for a high-level summary of the key provisions of the draft, amended regulations related to HCAs, municipal equity, social consumption, and suitability standards for marijuana establishment agents.
By Katelin Edwards, Andrea Golan
Aug 1, 2023
Between an unfavorable court ruling and an uninspiring 2021 legislative session, not to mention a major drought impacting all Texas crops, things were not looking good for hemp in Texas going into the 2023 legislative session. Then, many of the promising bills introduced in the 2023 legislative session were unsuccessful. Where does the Texas hemp market go from here? Read this article for four predictions from Vicente's hemp team.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.
